Ultimovacs ASA
OSE:ULTI.OL
107.4 (NOK) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) NOK.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.678 | 0.713 | 0.715 | 0.686 | 0.691 | 0.691 | 0.699 | 0.694 | 0.678 | 0.646 | 0.63 | 0.623 | 0.634 | 0.696 | 0.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -0.678 | -0.713 | -0.715 | -0.686 | -0.691 | -0.691 | -0.699 | -0.694 | -0.678 | -0.646 | -0.63 | -0.623 | -0.634 | -0.696 | -0.75 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 14.18 | 26.271 | 21.629 | 34.3 | 26.422 | 40.711 | 22.401 | 40.959 | 24.176 | 15.639 | 14.401 | 40.534 | 17.151 | 21.397 | 17.654 | 12.312 | 14.981 | 19.68 | 17.687 | 19.745 | 6.397 | 5.072 | 4.314 | 4.516 | 3.866 | 6.45 | 2.125 | 4.964 | 2.475 | 2.59 | 2.8 |
| General & Administrative Expenses
| 0 | 2.404 | 2.637 | 1.529 | 0.788 | 2.511 | 1.648 | 1.825 | 2.699 | 1.823 | 2.899 | 1.306 | 1.224 | 1.73 | 0.801 | 1.43 | 0.991 | 0.663 | 0.895 | 0.544 | 0.56 | 1.634 | 0.919 | 2.264 | 1.643 | 1.902 | 0.833 | 0.198 | 0 | 0.182 | 0.016 |
| Selling & Marketing Expenses
| 0 | 16.452 | 3.667 | 31.18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 14.445 | 18.856 | 6.304 | 32.709 | 0.788 | 2.511 | 1.648 | 1.825 | 2.699 | 1.823 | 2.899 | 1.306 | 1.224 | 1.73 | 0.801 | 1.43 | 0.991 | 0.663 | 0.895 | 0.544 | 0.56 | 1.634 | 0.919 | 2.264 | 1.643 | 1.902 | 0.833 | 0.198 | 0 | 0.182 | 0.016 |
| Other Expenses
| 0 | 7.107 | 0 | 0 | 0 | 0 | 26.713 | 29.469 | 17.179 | 17.959 | 14.6 | 9.09 | 24.14 | 16.043 | 12.762 | 11.846 | 15.145 | 15.84 | 12.677 | 7.545 | 12.361 | -2.61 | 9.737 | 6.684 | 11.676 | 6.556 | 8.01 | 2.725 | 6.006 | 5.447 | 5.989 |
| Operating Expenses
| 28.625 | 45.127 | 27.933 | 67.009 | 54.705 | 50.641 | 50.762 | 72.253 | 44.054 | 35.421 | 31.9 | 50.93 | 42.515 | 39.17 | 31.217 | 25.588 | 31.117 | 36.183 | 31.259 | 27.834 | 19.318 | 4.096 | 14.97 | 13.464 | 17.185 | 14.908 | 10.968 | 7.887 | 8.481 | 8.219 | 8.805 |
| Operating Income
| -29.303 | -45.84 | -28.648 | -67.695 | -54.705 | -50.641 | -50.763 | -72.255 | -44.055 | -35.421 | -31.9 | -50.929 | -42.517 | -39.171 | -31.215 | -25.588 | -31.116 | -36.183 | -31.259 | -23.216 | -19.317 | -4.096 | -14.97 | -13.462 | -17.185 | -14.908 | -10.967 | -7.887 | -8.479 | -8.219 | -8.806 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 3.477 | 0.555 | 5.895 | 3.696 | -1.117 | 7.266 | 16.652 | 1.742 | 5.752 | 13.045 | -4.7 | -0.223 | -0.791 | 2.706 | -2.583 | 1.007 | 0.391 | 1.274 | 0.922 | 2.47 | 2.082 | 0.252 | 0.247 | 0.767 | 0.284 | 0.142 | 0.048 | 0.263 | 0.059 | 0.245 | -0.005 |
| Income Before Tax
| -25.826 | -44.767 | -22.752 | -55.931 | -55.822 | -43.375 | -34.111 | -70.513 | -38.303 | -22.376 | -36.6 | -51.152 | -43.308 | -36.465 | -33.798 | -24.581 | -30.725 | -34.909 | -30.337 | -25.363 | -17.235 | -3.844 | -14.723 | -12.695 | -16.901 | -14.765 | -10.919 | -7.624 | -8.42 | -7.974 | -8.811 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 4.015 | 0 | 0.672 | 0.642 | 4.229 | 8.325 | -16.652 | -17.103 | -5.752 | -13.045 | 4.7 | 0.557 | 0.791 | -2.706 | 2.583 | -3.834 | -0.391 | -1.274 | -0.922 | -5.315 | -2.082 | -0.252 | -0.247 | -1.376 | -0.284 | -0.143 | -0.048 | -0.561 | -0.059 | -0.245 | 0.005 |
| Net Income
| -25.826 | -44.767 | -22.752 | -55.931 | -55.822 | -43.375 | -17.459 | -53.41 | -32.551 | -9.331 | -41.3 | -51.709 | -44.099 | -33.759 | -36.381 | -20.747 | -30.334 | -33.635 | -29.415 | -20.048 | -15.153 | -3.592 | -14.476 | -11.319 | -16.617 | -14.622 | -10.871 | -7.063 | -8.361 | -7.729 | -8.816 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.75 | -1.3 | -0.66 | -1.63 | -1.62 | -1.26 | -0.51 | -1.56 | -0.95 | -0.27 | -1.21 | -1.6 | -1.38 | -1.05 | -1.14 | -0.69 | -0.95 | -1.15 | -1.06 | -0.87 | -0.54 | -0.18 | -0.52 | -0.71 | -1.04 | -0.91 | -0.68 | -0.46 | -0.52 | -0.48 | -0.55 |
| EPS Diluted
| -0.75 | -1.3 | -0.66 | -1.63 | -1.62 | -1.26 | -0.51 | -1.56 | -0.95 | -0.27 | -1.21 | -1.6 | -1.38 | -1.05 | -1.14 | -0.69 | -0.95 | -1.15 | -1.06 | -0.87 | -0.54 | -0.18 | -0.52 | -0.71 | -1.04 | -0.91 | -0.68 | -0.46 | -0.52 | -0.48 | -0.55 |
| EBITDA
| -24.61 | -43.788 | -21.675 | -58.94 | -49.785 | -41.624 | -32.877 | -69.547 | -37.218 | -21.112 | -30.045 | -50.306 | -38.238 | -34.892 | -29.498 | -28.811 | -29.333 | -34.129 | -29.154 | -29.961 | -16.636 | -3.335 | -14.221 | -13.883 | -16.673 | -14.595 | -10.772 | -8.062 | -8.286 | -7.833 | -8.676 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |